COMMUNIQUÉS West-GlobeNewswire

IBA - Publication relative à une notification de transparence
06/06/2019
Louvain-la-Neuve, Belgique, 6 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Aleafia Health Announces $35 Million Public Offering of 8.5% Convertible Debenture Units
06/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, June 06, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (“ Aleafia Health ” or the “ Company ”) (TSX: ALEF) (OTC [...]
Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease
06/06/2019
BEVERLY, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, has signed an agreement with BDD Pharma, an award-winning drug [...]
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership with EmCyte Corporation
06/06/2019
WAYNE, N.J., June 06, 2019 (GLOBE NEWSWIRE) -- As part of its commitment to supporting education for ultrasound-guided musculoskeletal interventions, Konica Minolta Healthcare announces a new autologous biologics [...]
Medifirst Solutions Gets Approval for Merchant Account for Hemp and CBD Products
06/06/2019
Freehold, NJ, June 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
Chiesi Group is the largest pharmaceutical group in the world to be awarded B Corp certification
06/06/2019
Certified B Corporations meet the highest standards of verified social and environmental performance, transparency and accountability. Chiesi Group receives the B Corp certification from B Lab, a leading global [...]
Visual Healthcare Corp. (OTC: VSHC) Announces Submission of Financials and Next Steps
06/06/2019
Houston, TX, June 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Visual Healthcare Corp. (OTC PINK: VSHC) announces today that all financial reports have now been uploaded to OTC Markets. This was the final step in [...]
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis
06/06/2019
- Treatment with LJPC-401 Resulted in Statistically Significant Reduction in Change in Transferrin Saturation (TSAT), the Primary Efficacy Endpoint of the Study, and Frequency of Phlebotomies, a Key Secondary Efficacy [...]
Tergus Pharma Announces New Commercial Manufacturing Facility and Partnership with Great Point Partners
06/06/2019
Tergus Is Poised for Growth & Expansion by Adding Commercial Capabilities And Expanding Current Capacity RESEARCH TRIANGLE PARK, N.C. and DURHAM, N.C., June 06, 2019 (GLOBE NEWSWIRE) -- Tergus Pharma (“Tergus”), an [...]
OLAH Healthcare Technology welcomes Wayne Trochmann as Vice President of Sales
06/06/2019
COLUMBUS, Ohio, June 06, 2019 (GLOBE NEWSWIRE) -- Wayne Trochmann has been recently named Vice President of Sales for OLAH Healthcare Technology. Trochmann will focus on evolving the go-to-market strategy to grow [...]
Agritek Holdings, Inc. Announces Uplisting to OTCQB as Company Rolls Out National Line of Full Spectrum Hemp Oil Topicals and Edibles
06/06/2019
LOS ANGELES, CA, June 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant [...]
Vice President to Expand RenovaCare SkinGun™ Technology for New Medical Conditions Beyond Burns
06/06/2019
SCOTTSDALE, Ariz., June 06, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com ) developer of patented technologies for spraying a patient’s own stem cells onto burns and wounds for [...]
Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, Named Finalist for The 2019 EY Entrepreneur Of The Year® Award in New Jersey
06/06/2019
Mr. Luther joins the ranks of unstoppable entrepreneurs in New Jersey region Newark, NJ, June 06, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer [...]
Spring Bank Announces Presentation of Promising Results from Study Highlighting Immune-Activation with Inarigivir 400mg
06/06/2019
HOPKINTON, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange
06/06/2019
SAN CARLOS, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that a reverse stock [...]
INSIGHT: First Patient Dosed in the 4th arm called “INSIGHT-004”
06/06/2019
Highlights First patient received first dose in INSIGHT-004, a phase I clinical trial Evaluates the combination of eftilagimod alpha with avelumab (BAVENCIO®) in different cancer indications Patient recruitment for the [...]
Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment
06/06/2019
A single ILUVIEN implant significantly delayed recurrence and reduced uveitis symptoms upon recurrence compared to active control arm Recently approved in Europe, ILUVIEN is expected to launch in certain EU countries [...]
ContraVir Pharmaceuticals Sets the Stage for CRV431 Development in NASH with Positive Results from Second Model of Liver Fibrosis
06/06/2019
- Further evidence of unique mechanism beneficial to NASH treatment - EDISON, N.J., June 06, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development [...]
Tabula Rasa HealthCare’s DoseMe Signs 3-Year Agreement with Portugal’s National Health Service
06/06/2019
Recognizes the importance of individualizing medication therapy for every patient MOORESTOWN, N.J., June 06, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), precision dosing software [...]

Pages